Corestate Capital (ETR:CCAP) PT Set at €58.00 by Berenberg Bank

Berenberg Bank set a €58.00 ($67.44) price objective on Corestate Capital (ETR:CCAP) in a research note issued to investors on Tuesday, Borsen Zeitung reports. The brokerage currently has a buy rating on the stock.

A number of other equities research analysts also recently issued reports on CCAP. Oddo Bhf set a €47.00 ($54.65) price target on Corestate Capital and gave the company a buy rating in a research note on Wednesday, May 15th. Hauck & Aufhaeuser set a €45.00 ($52.33) price target on Corestate Capital and gave the company a buy rating in a research note on Tuesday, August 6th. Finally, Kepler Capital Markets set a €70.00 ($81.40) price target on Corestate Capital and gave the company a buy rating in a research note on Tuesday, May 14th. Eight research analysts have rated the stock with a buy rating, Corestate Capital has a consensus rating of Buy and an average price target of €62.00 ($72.09).

Corestate Capital stock opened at €28.55 ($33.20) on Tuesday. The business has a 50-day simple moving average of €31.81 and a two-hundred day simple moving average of €31.92. The company has a market cap of $609.67 million and a P/E ratio of 6.25. Corestate Capital has a 52-week low of €25.45 ($29.59) and a 52-week high of €48.20 ($56.05). The company has a quick ratio of 0.61, a current ratio of 2.13 and a debt-to-equity ratio of 103.04.



About Corestate Capital

CORESTATE Capital Holding SA is a real estate investment firm specializing in investments in small to medium sized residential portfolios and commercial real estate markets. The firm seeks to invest in an "anti-cyclical" manner in Europe and expand its club-style deals from purely opportunistic to core-plus and value-add investments.

Further Reading: What type of investment options does a Roth IRA provide?

Analyst Recommendations for Corestate Capital (ETR:CCAP)

Receive News & Ratings for Corestate Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corestate Capital and related companies with MarketBeat.com's FREE daily email newsletter.